R&D Reference Number Project Short title Project Full title Recruitment end date
1701366 The FoND Study The FoND Study 31/08/2018
1407957 TIGI Type 1 Diabetes, Immunology, Genetics and endogenous Insulin production 30/09/2018
1608298 The effects of BAY 1193397 A randomized, single blind, threefold crossover, single center study to assess the safety and the effects of 1 mg and 5 mg BAY 1193397 in comparison to placebo on skin capillary blood flow and transcutaneous oxygen pressure after single dose in type II diabetic patients with peripheral artery disease 30/09/2018
1703396 StartRight (Main Study) StartRight: Getting the right classification and treatment from diagnosis in young adults with diabetes 30/09/2018
1805634 SOTA-EMPA A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin compared to Empagliflozin, and Placebo in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control on Dipeptidyl Peptidase 4 Inhibitor (DPP4(i)) With or Without Metformin 30/11/2018
1206659 DRN 552 (Incident and high risk type 1 diabetes cohort – ADDRESS-2) An incident and high risk type 1 diabetes research cohort – After Diagnosis Diabetes REsearch Support System-2 (ADDRESS-2) 31/12/2018
1712543 Phase 1 study of IMCY-0098 in Recent Onset Type 1 Diabetes A PHASE I, PLACEBO CONTROLLED, DOUBLE-BLIND, DOSE ESCALATION CLINICAL TRIAL TO EVALUATE THE SAFETY AND IMMUNE RESPONSES OF IMCYSE’s IMCY-0098 IN PATIENTS WITH RECENT ONSET TYPE 1 DIABETES. 31/12/2018
1507116 DIabetes VAriants (DIVA) – Exeter DIabetes VAriants (DIVA) – Exeter 04/02/2019
1207681 DRN100 (TrialNet) TrialNet Natural History Study of the Development of Type 1 Diabetes. Phase 1,2 and 3. 01/09/2019
1706442 NIRS for the measurement of haemodynamic markers in bone tissue (V1). The use of near infra-red spectroscopy as a diagnostic tool to measure haemodynamic markers of the microvascular blood supply in bone tissue. 01/09/2019
1804570 The VIBE Study The Vascular actions of glucagon-like peptide-1 analogues and its mediators in people with type 2 diaBetes and diabetic rEtinopathy 31/10/2019
1603221 TriMaster v1 Randomised Double-Blind Crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as third line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on dual therapy with metformin and a sulphonylurea 31/01/2020
1706443 EXE-T1D – EXtremely Early-onset Type 1 Diabetes Understanding beta-cell destruction through the study of
EXtremely Early-onset Type 1 Diabetes
(A Musketeers’ Memorandum study)
31/07/2020
1810690 ICCD Improving Clinical Care in Diabetes 01/03/2022
1308826 Genetic Beta Cell Research Bank inc Extension Genetic Beta Cell Research Bank inc Extension 18/11/2022
1808661 BEAT-DKD Exeter Novel imaging biomarkers to beat diabetic kidney disease 31/12/2037